LumiThera is a clinical-stage medical device company focused on the use of photobiomodulation (PBM), using non-invasive light emitting diodes (LED) to treat patients with acute and chronic ocular diseases and disorders. The Company is currently developing an ophthalmologist LED office-based instrument to be used in treating dry Age-related Macular Degeneration.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/31/17 | $5,500,000 | Series B |
RPR Venture WaterStone Capital  | undisclosed |
| 07/13/20 | $14,000,000 | Series C |
Celeste Management Imagine Ventures Keiretsu Capital Fund Nikon WaterStar Capital | undisclosed |
